Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Repression of Bleomycin-Induced Pneumopathy by TNF

Misuzu Kuroki, Yuji Noguchi, Michihide Shimono, Kazunori Tomono, Takayoshi Tashiro, Yuichi Obata, Eiichi Nakayama and Shigeru Kohno
J Immunol January 1, 2003, 170 (1) 567-574; DOI: https://doi.org/10.4049/jimmunol.170.1.567
Misuzu Kuroki
*Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuji Noguchi
†Department of Immunology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michihide Shimono
†Department of Immunology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazunori Tomono
*Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takayoshi Tashiro
*Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuichi Obata
‡RIKEN BioResource Center, Tsukuba Institute, Tsukuba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eiichi Nakayama
†Department of Immunology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeru Kohno
*Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Cellular composition in BALF. Number of cells in BALF harvested from TNF+/+ (open bars) and TNF−/− (filled bars) mice after BLM instillation (a) or sterile PBS treatment (b). BALF on day 0 was harvested from nontreated mice. Data represent mean ± SEM (n = 5 for each group). ∗, p < 0.01. ∗∗, Few of neutrophils and lymphocytes were observed in nontreated mice.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Cellular composition of lung cells. Number of cells in lungs isolated from TNF+/+ (open bars) and TNF−/− (filled bars) mice on 21 days after BLM instillation (a) or sterile PBS treatment and none (b). Data represent mean ± SEM (n = 5 for each group). ∗, p < 0.01.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Histological analysis of lung damage induced by BLM. Lungs were collected on days 14 (a, b) and 75 (c, d) after BLM injection. Lungs from TNF+/+ (a, c) and TNF−/− (b, d) mice. The paraffin sections were H&E stained and photographed at ×40 magnification. Results are representative of four mice in each group.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Hydroxyproline content in lungs after BLM instillation. Lungs were collected on day 21 after BLM or sterile PBS injection. Hyroxyproline content was measured in TNF+/+ (open bars) and TNF−/− (filled bars) mice. Data represent mean ± SEM (n = 5 for each group).

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Production of TNF in lungs and expression of TNFRs after BLM instillation. a, TNF production in lungs was determined by ELISA. TNF+/+ (•) and TNF−/− mice (○). Data represent mean ± SEM (n = 5 for each group). b and c, Flow cytometric analysis of expression of TNFRs on inflammatory cells in BALF. Numbers represent percentage of TNFR-positive cells. Results are representative of five mice.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Apoptotic cells in the bronchoalveolar space after BLM instillation. a, Detection of apoptotic cells by flow cytometric analysis. BAL was performed on day 14 after BLM. Numbers represent percentage of annexin V- and/or propidium iodide-positive cells. Results are representative of five mice. b, Annexin V-positive cells were counted as apoptotic cells. TNF+/+ mice (open bars) and TNF−/− (filled bars). Data represent mean ± SEM (n = 5 for each group), except for those obtained on day 28, which represent pooled inflammatory cells harvested from five mice. ∗, p < 0.05.

  • FIGURE 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7.

    Effects of airway challenge with rTNF on induction of apoptosis of inflammatory cells. a, Number of inflammatory cells in the BALF harvested from TNF−/− mice challenged via airways with murine rTNF (filled bars) or PBS alone (open bars) after BLM. The concentration of murine rTNF was 250 ng/ml in PBS. BAL was performed 48 h after airway challenge with TNF. Data represent mean ± SEM (n = 5 for each group). ∗, p < 0.01. b, Number of inflammatory cells in BALF harvested from TNF−/− mice challenged with murine (filled bars) or human rTNF (open bars) on day 14 after BLM instillation. TNF concentration was 250 ng/ml in PBS. BAL was performed sequentially after airway challenge with TNF. Data represent mean ± SEM (n = 5 for each group). ∗∗, p < 0.05. ND, not done. c, Detection of apoptotic cells by flow cytometric analysis. Cells were harvested from TNF−/− mice challenged with murine or human rTNF on day 14 after BLM. BAL was performed 6 h after airway challenge with TNF. Numbers represent percentage of annexin V- and/or propidium iodide-positive cells. Results are representative of five mice. d, Number of inflammatory cells in BALF harvested from TNF−/− mice challenged with various concentrations of murine rTNF on day 14 after BLM instillation. BAL was performed 48 h after airway challenge with murine TNF. Data represent mean ± SEM (n = 5 for each group). ∗∗, p < 0.05.

  • FIGURE 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 8.

    Effects of long-term challenge with murine rTNF on pulmonary inflammation. Challenge via airways with 250 ng/ml murine TNF solution was started on day 14 after BLM and repeated twice weekly for 4 wk. a and b, Histological analysis of lungs harvested from murine TNF-treated (a) or untreated (b) TNF−/− mice. The paraffin sections were H&E stained and photographed at ×40 magnification. Lungs were harvested on day 42 after BLM. Only unilateral lungs were macroscopically and histologically damaged in murine TNF-untreated TNF−/− mice. Results are representative of three mice in each group. c, Percentage of survival of mice. TNF−/− mice challenged with mouse TNF (○; n = 8) or sterile PBS (•; n = 8). TNF+/+ mice (Δ; n = 8) for control. It was confirmed that bilateral lungs were histologically damaged in all mice at the time of death or sacrifice on day 42 after BLM instillation. Data from two experiments were combined.

PreviousNext
Back to top

In this issue

The Journal of Immunology: 170 (1)
The Journal of Immunology
Vol. 170, Issue 1
1 Jan 2003
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Repression of Bleomycin-Induced Pneumopathy by TNF
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Repression of Bleomycin-Induced Pneumopathy by TNF
Misuzu Kuroki, Yuji Noguchi, Michihide Shimono, Kazunori Tomono, Takayoshi Tashiro, Yuichi Obata, Eiichi Nakayama, Shigeru Kohno
The Journal of Immunology January 1, 2003, 170 (1) 567-574; DOI: 10.4049/jimmunol.170.1.567

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Repression of Bleomycin-Induced Pneumopathy by TNF
Misuzu Kuroki, Yuji Noguchi, Michihide Shimono, Kazunori Tomono, Takayoshi Tashiro, Yuichi Obata, Eiichi Nakayama, Shigeru Kohno
The Journal of Immunology January 1, 2003, 170 (1) 567-574; DOI: 10.4049/jimmunol.170.1.567
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Suppression of inflammation in collagen-induced arthritis by administration of recombinant Fcγ receptors (54.17)
  • The immunological ménage à trois promotes inflammation in Type 2 diabetes. (54.14)
  • Identification of novel small molecule inducers of endothelium-driven innate immunity (54.10)
Show more Inflammation

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606